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Human ESCs are the pluripotent precursor of the
three embryonic germ layers. Human ESCs exhibit
basal-apical polarity, junctional complexes, integrin-
dependent matrix adhesion, and E-cadherin-depen-
dent cell-cell adhesion, all characteristics shared
by the epiblast epithelium of the intact mammalian
embryo. After disruption of epithelial structures, pro-
grammed cell death is commonly observed. If indi-
vidualized human ESCs are prevented from reattach-
ing and forming colonies, their viability is significantly
reduced. Here, we show that actin-myosin contrac-
tion is a critical effector of the cell death response
to human ESC dissociation. Inhibition of myosin
heavy chain ATPase, downregulation of myosin
heavy chain, and downregulation of myosin light
chain all increase survival and cloning efficiency
of individualized human ESCs. ROCK inhibition
decreases phosphorylation of myosin light chain,
suggesting that inhibition of actin-myosin contrac-
tion is also the mechanism through which ROCK
inhibitors increase cloning efficiency of human ESCs.
INTRODUCTION
Embryonic stem cells (ESCs) can proliferate without limit and can
differentiate to all cell types of the body (Evans and Kaufman,
1981; Martin, 1981; Thomson et al., 1998). Although human
and mouse ESCs share these basic properties, they are distinct
in cell surface markers, morphology, and growth factor require-
ments. These differences now appear to reflect different embry-
ological origins rather than species specific differences, given
that human ESCs more closely resemble pluripotent cell lines
derived from the epithelial cells of the mouse epiblast (EpiSC)
(Brons et al., 2007; Tesar et al., 2007). Human ESCs clone at
a very poor efficiency under standard culture conditions, prob-
ably reflecting their growth in compact, epithelial colonies (Krtol-
ica et al., 2007). Epithelia are tightly coupled by junctions and
are separated from stroma by basement membranes, both of
which restrict movements between body compartments. Human
ESCs are generally grown on matrices that resemble basement240 Cell Stem Cell 7, 240–248, August 6, 2010 ª2010 Elsevier Inc.membranes and form colonies with ultrastructural characteris-
tics similar to the epiblast epithelium with tight junctions and
apical microvilli (Krtolica et al., 2007; Sathananthan et al.,
2002). Cell-cell junctions between human ESCs also include
gap junctions and E-cadherin-mediated cell adhesion (Ullmann
et al., 2007;Wong et al., 2004). Cell-matrix adhesion is necessary
for human ESC survival and involves binding through b1 and
a integrins (Braam et al., 2008).
The proliferation and survival of cells in epithelial structures are
tightly controlled in vivo, and epithelial cells placed out of their
normal environment often die through a process termed anoikis
(‘‘homeless’’), a specialized form of programmed cell death due
to tissue disorganization. Anoikis can result from both caspase-
dependent and independent pathways (Wang et al., 2003) and is
initiated by the disruption of the junctions with the basement
membrane and between adjacent epithelial cells (Ellerstrom
et al., 2007; Watanabe et al., 2007). Without drug treatment that
blocks specific effectors of anoikis, dissociated epithelial cells
die in suspension (Watanabe et al., 2007). Anoikis is normally
prevented by integrin-mediated extracellular matrix signaling
and cadherin-mediated cell-cell signaling (Ndozangue-Touri-
guine et al., 2008; Simpson et al., 2008). Integrin- and cadherin-
mediated signaling pathways influence epithelial cell shape,
polarization, and survival through interactions with the cytoskel-
eton, and disruption of these adhesion pathways dramatically
alters cytoskeletal architecture.
The actin-myosin based cytoskeleton is a dynamic system
essential for contraction, motility, and tissue organization (Even-
Ram et al., 2007; Ivanov, 2008; Ivanov et al., 2007; Montell,
2008). Actin-myosin motors consist of actin filaments and non-
muscle myosin II heavy chains (MYHs). Actin filaments are often
anchored on integrins and E-cadherins through focal-adhesion
and a/b catenin complexes, respectively. The hydrolysis of
ATP by the MYH ATPase generates energy and causes the
MYHs to slide along actin filaments, resulting in contraction.
The process is triggered by the binding of myosin light chain
(MLC), which is activated by phosphorylation through kinases,
such as Rho-associated kinase (ROCK) or MLC kinase (MLCK)
(Quintin et al., 2008). In order to maintain normal morphology
and function, a balance has to be achieved between actin-
myosin contraction forces and opposing anchoring forces
(Lecuit and Lenne, 2007; Montell, 2008; Okeyo et al., 2009).
If cells are removed from the restraint of their extracellular matrix
and cell contacts, the balance is broken and actin-myosin is free
to contract, generating altered phenotypes, including excessive
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Ivanov et al., 2005; Sathananthan et al., 2002). Without re-estab-
lishing cell adhesion, the excessive actin-myosin contraction can
ultimately result in cell death.
Here, we report that disruption of actin-myosin contraction in
individualized human ESC dramatically improves cell survival
and cloning efficiency. Blebbistatin is a nonmuscle myosin II
heavy chain inhibitor and is named after its ability to specifically
inhibit membrane blebbing (Limouze et al., 2004; Straight et al.,
2003). We find that blebbistatin not only represses cell blebbing
of human ESCs, but also dramatically improves cell survival
and cloning efficiency in defined conditions. Furthermore, we
observe that other approaches to disrupting actin-myosin con-
traction, including downregulation of myosin heavy chain
mRNAs or downregulation of myosin light chain, replicate the
effects of blebbistatin both on human ESC membrane blebbing
and survival. Recently, inhibition of ROCKwas shown to regulate
cloning efficiency and epithelial structure of human ESCs. We
find that actin-myosin contraction is a downstream target of
ROCK regulation in cloning and survival. Our combined results
demonstrate a central role of actin-myosin contraction in the
death of dissociated human ESCs.RESULTS
Cell-Cell Contact Promotes Human ESC Survival
Most individualized human ESCs die when left in suspension or
when plated at clonal cell densities, even when plated on an
appropriate matrix that normally supports human ESCs plated
in clumps. This cell death could be due to damage associated
with cell dissociation or could be due to a lack of cell-cell survival
signals. We first sought to examine the time course of cell death
and proliferation of individualized human ESCs (Figure 1A). Most
human ESCs attached to the plate in less than 1 hr and migrated
extensively in the first few hours (Movie S1 available online).
However, cells started to detach and die at 6 hr. The number
of attached cells that remained reached a low point by 12 hr,
and after 24 hr, cell numbers stabilized or increased, depending
on plating density. When the number of surviving, attached
cells over time was plotted as a percentage of the cells initially
plated, both initial survival and subsequent increase in cell
number were higher for cells plated at higher density (Fig-
ure 1A). We found that cell survival increases with direct cell-
cell contact (Figure S1A), which depends on E-cadherin
(Figure S1B and Movie S1C).
Blebbistatin Inhibits Cell Blebbing after Dissociation
Because human ESCs share an epithelial ultrastructure with the
epiblast, and because cell contact is important in human ESC
survival, we examined whether cell death of individualized
human ESCs shares features of the anoikis observed in other
epithelial cell types. Pronounced membrane blebbing, observed
after the dissociation of epithelial cells, is an indicator of actin-
myosin cytoskeletal contraction and is often a prelude to cell
death (Coleman et al., 2001; Croft et al., 2005). We observed
bubble-shaped membrane protrusions on the surface of human
ESCs just seconds after cells were individualized (Figure 1B).
The membrane blebbing was suppressed by blebbistatin, amyosin heavy chain ATPase inhibitor, implicating actin-myosin
contraction in human ESC blebbing (Figure 1B). We next used
Phalloidin to visualize the actin filament organization in dissoci-
ated cells. Ring-shaped actin structures, characteristic of
blebbing in other cell types, were observed only in untreated
cells (Figure 1B) and persisted for up to a few hours after plating
(Figure 1C). Without drug treatment, blebbing was eventually
suppressed at the site of cell-cell junctions of those human
ESCs that did successfully form clusters after plating and
attachment (Figure S1C). When blebbistatin was added during
human ESC plating, it not only inhibited cell blebbing, but also
helped cells attach and spread on the matrigel plates after
3060 min of treatment (Figure 1C). Most individualized human
ESCs treated with blebbistatin that survived on matrigel for
24 hr formed loose colonies with distinct cell boundaries
(Figure 1D).
Blebbistatin Increases Cell Survival and Cloning
Efficiency of Human ESCs
Membrane blebbing can cause cell death (Croft et al., 2005), so
we examinedwhether inhibition ofmembrane blebbing improves
human ESC survival. Blebbistatin improved survival of human
ESCs examined at 24 hr (Figure 1E) and supported an increased
cloning efficiency of cells plated at low density and examined for
colony formation after 5 days (Figure 1F). Time-lapse photog-
raphy confirmed that blebbistatin facilitated colony formation
through the proliferation of a single cell, not by aggregation
(Movie S1B). Comparable effects of blebbistatin on cloning
efficiency were observed in two human ESC lines (H1 and H9),
and two human iPSC lines (iPSimr90C4 and iPSforeskinC6.1)
(Yu et al., 2007) (Table S1). After blebbistatin treatment, human
ESCs were passaged five times and continued to express ESC
markers, includingOCT4 (Figure S1D), maintained normal karyo-
types (Figure S1E), and formed teratomas. Blebbistatin also
helped cell attachment (Figure S1F) and improved human ESC
survival on tissue culture plates not treated with matrigel. Bleb-
bistatin also helped survival of suspended human ESCs exam-
ined at 24 hr (Figures S1G and S1H). Combined, our results
suggest that inhibition of myosin function by blebbistatin
reduces the requirement for cell-cell and cell-matrix associated
signaling in the survival of human ESCs.
MYH9 Is the Major Human ESC Target for Blebbistatin
in Survival and Cloning
Blebbistatin is a myosin II heavy chain inhibitor whose binding
requires four conserved amino acids in the myosin cleft (Alling-
ham et al., 2005; Limouze et al., 2004). Because MYH9 and
MYH10 are the most highly expressedMYHs with the conserved
sites in human ESCs, we first used SMARTPool siRNAs to knock
down their mRNAs (Table S2). Knockdown efficiency and spec-
ificity were examined with quantitative RT-PCR (Table S3 and
Figure S2A). Normal morphology and growth were observed
after MYH10 siRNA treatment. In a few days, slower cell growth
and stretched pseudopods were observed in cells treated with
MYH9 siRNA, and the phenotypic changes were most severe
when cells were treated with both MYH9 and MYH10 (MYH9/
MYH10) siRNAs (Figure 2A). Similar to the effect of blebbistatin,
the blebbing phenotype was suppressed after dissociation when
MYH9 or MYH9/MYH10 was silenced (Figure 2B). The silencingCell Stem Cell 7, 240–248, August 6, 2010 ª2010 Elsevier Inc. 241
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Figure 1. Inhibition of Membrane Blebbing Improves Cell Viability after Dissociation in Human ESCs
(A) A time course of density-dependent survival after dissociation. Different numbers of human ESCs were plated onto each well (3,000/cm2 [3K, blue diamond],
10,000/cm2 [10K, red square], and 30,000/cm2 [30K, green triangle]). The ‘‘Survival Index’’ represents the number of surviving cells divided by the number of input
cells. (Note that as cells divide, this index can eventually exceed 100%.) One asterisk signifies that the 10K density survival index differed significantly (p < 0.05)
from the 3K density survival at 24 hr. Two asterisks signifie that the 30K density survival index differed significantly (p < 0.05) from the 10K survival at 24 hr.
For more details, see Experimental Procedures, ‘‘Statistics.’’
(B) Phase contrast images of human ESCs dissociated by TrypLE with or without 10 mM blebbistatin. Blebbistatin changed actin organization immediately after
dissociation, as visualized by Alexa-633 conjugated phalloidin (Red).
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plating, compared with control cells (Figure 2C). Knockdown of
MYH9 or MYH9/MYH10 improved both initial cell survival
(Figure 2D) and cloning efficiency (Figure 2E). Time-lapse exper-
iments confirmed that colonies were formed from single cells in
MYH9 andMYH9/MYH10 siRNA-treated cells. Cells treated with
MYH10 siRNA alone behaved comparably to control cells
(Figure 2). MYH’s role was further confirmed by using individual
siRNA duplexes and select siRNAs that employed a different
duplex design (Table S2; Figures S2B, S2C, and S2H–S2K).
All the results demonstrated thatMYH9 silencing inhibited bleb-
bing, and improved cloning efficiency, whereas MYH10 siRNA-
treated cells behaved comparably to control cells.
Inhibition of Myosin Light Chain Suppressed Cell Death
after Dissociation
MYH-actin contraction is activated through phosphorylated
myosin light chain (MLC). We tested whether reduction of MLC
levels could also inhibit cell death. We used SMART pool siRNAs
to knock down all three MCL family members (MRLC1, MRLC2
and MRLC3) in human ES cells (Table S2 and Figure S2D).
When each gene was individually silenced, membrane blebbing
was not repressed and cloning efficiency was not improved
(Figures S3A-B). However, when all three genes (MRLC1/2/3)
were silenced together, cells spread and stretched widely on
plate surfaces, exhibiting the same morphology and reduced
growth rate asMYH9/MYH10 knockdown cells (Figure 3A). Bleb-
bing was inhibited after dissociation (Figure 3B), and both initial
cell survival and cloning efficiency were improved (Figures 3C
and 3D). These findings were also confirmed with a separate
set of siRNAs (Table S2; Figures S2E and S3C and S3D), and
further support that MYH motors are involved in human ESC
blebbing and cell death and that the motors are regulated
through MLC.
Actin Disruption Increased Initial Survival and Cloning
Efficiency of Dissociated Human ESCs
Cell blebbing involves actin-based protrusions (Figures 1B and
1C), andmyosinmotors require intact actin filaments to contract.
Here, we tested whether the disruption of actin filaments could
prevent myosin-dependent cell death. Among commonly used
actin disruption drugs, Cytochalasin D binds to actin barbed
ends to prevent actin-filament polymerization, whereas Swinho-
lide A and Mycalolide B sever actin filaments. All three actin
inhibitors suppressed membrane blebbing (Figure 3E). Twenty-
four hours of continuous treatment resulted in significant
improvement of cell survival (Figure 3F), but no colony formation
at low density after 5 days. However, Swinholide A treatment
limited to 3 hr after plating improved cloning efficiency, but not(C) Blebbistatin inhibited blebbing and improved cell spreading 1 hr after plating
(D) Colony morphology of human ESCs 24 hr after splitting and treatment with b
(E) The 24 hr survival of individualized human ESCs was significantly improved w
Comparable experiments were repeated more than ten times.
(F) Treatment of human ESCs with blebbistatin for 1 hr or longer was sufficient to i
presence and absence of 10 mM Blebbistatin at a density of 150 cells/cm2. Bleb
calculated after 7 days (*p < 0.05). Comparable time series experiments were re
consistently increased the cloning efficiency of two human ESC lines (H1 and H9
See also Figure S1, Table S1, and Movie S1.as well as blebbistatin (Figure 3G). These results are not
surprising given that actin is involved in other essential cellular
functions besides myosin contraction (Grummt, 2006; Zheng
et al., 2009). Colonies formed after Swinholide A treatment
demonstrated a similar morphology to colonies formed after
blebbistatin treatment (Figure S3E).
MLC Is a Downstream Target of ROCK Kinase
in Human ESCs
ROCK kinases, either directly or indirectly, regulate MLC phos-
phorylation (Totsukawa et al., 2000), and it has been shown
previously that inhibition of ROCK improves cloning efficiency
of human ESCs (Krawetz et al., 2009; Watanabe et al., 2007).
Although the ROCK kinase inhibitor Y27632 is fairly specific,
contributory off-target effects of the inhibitor were not excluded,
and direct evidence that ROCK is the specific target of the
inhibitor for the observed increase in human ESC cloning effi-
ciency has been lacking. Here, we knocked down ROCK1 and
ROCK2 separately or together with SMART siRNA pools in
human ESCs (Table S2 and Figure S2F). We found that single
knockdown of either ROCK1 or ROCK2 alone did not inhibit
blebbing or improve cloning efficiency (Figure 4B and Fig-
ure S4A). However, when both ROCK1 and ROCK2 (ROCK1/
ROCK2) were downregulated, cells stretched more than control
cells (Figure 4A) and membrane blebbing was suppressed
(Figure 4B), similar to the phenotype observed in MYH and
MLC knockdown cells. ROCK1/ROCK2 siRNA treatment also
improved the survival and cloning of individualized human
ESCs (Figures 4C and 4D). These results were confirmed with
a different set of siRNAs against ROCKs (Table S2; Figures
S2G and S4B). Colonies formed after ROCK1/ROCK2 siRNA
treatment demonstrated morphology similar to normal human
ESCs, with high expression of the pluripotency marker OCT4
(Figures S3F and S3G).
We further tested whether ROCKs regulate MYH function
through MLC phosphorylation. Western blot showed that phos-
phorylation of MLC (Ser-19) was significantly increased after
individualized human ES cells were plated, and that the ROCK
inhibitor Y27632 (at 10 mM) suppressed the increased phosphor-
ylation (Figure 4E). Similarly, silencing of ROCK1/ROCK2 abol-
ished the increase of MLC phosphorylation (Figure 4F). We then
performed a dose response curve to examine whether ROCK-
controlled MLC phosphorylation correlated with improved
cloning efficiency. With increasing Y27632 concentration, MLC
phosphorylation decreased (Figure 4G), which correlated with
the improvement of cloning efficiency (Figure 4H). Similar exper-
iments were performed with another ROCK inhibitor H1152
(Figures S4C and S4D). These results further support that
ROCKs regulate MYH function through MLC phosphorylationas visualized by Alexa- staining.
lebbistatin.
hen 10 mM blebbistatin was added to cells plated at 10,000/cm2 (*p < 0.05).
mprove the cloning efficiency (*p < 0.05). Individualized cells were plated in the
bistatin was removed after indicated time points. Cloning efficiency was then
peated two times. In more than 40 single-time point experiments, blebbistatin
) and two iPSC lines (iPS-foreskin and iPS-IMR90) (see Table S1).
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Figure 2. Knockdown of Nonmuscle Myosin Heavy Chains Reduces Blebbing and Improves Survival and Cloning Efficiency of Human ESCs
Knockdown (by siRNA) of MYH9 alone or in combination with MYH10: (A) changed ESC morphology in colonies 96 hr after transfection, (B) reduced blebbing
immediately after dissociation, (C) increased attachment/spreading 5 hr after plating, (D) increased (*p < 0.05) survival 24 hr after plating, and (E) increased
(*p < 0.05) cloning efficiency. Comparable results were obtained in multiple experimental repetitions with both H1 (n = 15) and H9 human ESC lines (n = 2).
See also Figure S2 and Tables S2 and S3.
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cell death.
DISCUSSION
Our results suggest that actin-myosin contraction is a major
mechanism promoting death of individualized human ESCs.
By disrupting the contraction of the actin-myosin motor, either
by chemical inhibitors or by siRNA knockdown of individual
motor components, cell survival was dramatically improved.
Disruption of actin-myosin contraction by these approaches
also inhibited membrane blebbing, a phenotype of individualized
human ESCs that correlated with cell death. Cell blebbing is244 Cell Stem Cell 7, 240–248, August 6, 2010 ª2010 Elsevier Inc.caused by unbalanced stresses resulting from the loss of cell
anchorage and ultimately can lead to cell death if balance is
not restored (Charras et al., 2005). Individualized human ESCs
plated at a high density restored cell-cell contacts, reduced
cell blebbing, and survived at a high frequency, even without
exogenous inhibition of actin-myosin contraction. It is note-
worthy that immediately after plating individual human ESCs,
there was extensive cell migration and subsequent cell aggrega-
tion into colonies, so colony formation is not a direct measure of
cloning efficiency unless low plating densities are used.
We found that inhibition of actin-myosin contraction during
the initial hour after human ESC dissociation was the critical
time period for subsequent survival. For human ESCs plated at
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Figure 3. Knockdown ofMyosin Light Chain and Disruption of Actin Filaments Reduce Blebbing and Improve Survival and Cloning Efficiency
of Human ESCs
Knockdown (by siRNA) of the threeMLC gene products (MRLC1/2/3): (A) changed human ES cell morphology in colonies 96 hr after transfection, (B) decreased
blebbing immediately after dissociation, (C) increased (*p < 0.05) cell survival 24 hr after plating, and (D) increased (*p < 0.05) cloning efficiency. Disruption of actin
filaments by small molecules: (E) reducedmembrane blebbing of human ESCs 2 hr after plating in the presence of Cytochalasin D (100 nM), Swinholide A (10 nM),
or Mycalolide B (20 mM), (F) increased human ES cell Survival Index at 24 hr, and (G) increased cloning efficiency after an initial 2 hr treatment with Swinholide A
(10 nM).
See also Figure S3 and Tables S2 and S3.
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Myosin-Dependent Cell Death in Human ESCsclonal densities, this initial inhibition of actin-myosin contraction
would give some cells time to attach, divide, and re-establish
balanced contractile forces and cytoskeletal architecture
throughcell-matrix and cell-cell adhesion.Because actin-myosincontraction is also involved in the formation of the cleavage
furrow and cytokinesis (von Dassow, 2009) (Kanada et al.,
2005), long-term exposure to blebbistatin inhibits cell division,
and thus long exposures do not improve human ESC cloningCell Stem Cell 7, 240–248, August 6, 2010 ª2010 Elsevier Inc. 245
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0 0.3 1 3 10 30
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
Control
A
C
"Y27632 Removal"
Control ROCK1 siRNAB ROCK2 siRNA ROCK1/ROCK2 siRNA
D
E
C
lo
ni
ng
 E
ffi
ci
en
cy
g
y
0%
1%
2%
3%
4%
5%
6%
7%
8%
9%
10%
Time (hours) 0      1   2    4    6    0    1    2    4     6
p-MLC
MLC
Time (hours)
MLC
p-MLC
0    1    2    4     6
Control Y27632
ROCK1/ROCK2 siRNA
F
Y27632 (µM)
p-MLC
MLC
0    0.3    1      3    10  30
G H
24
hr
 S
ur
vi
va
l I
nd
ex
Control ROCK1 siRNA ROCK2 siRNA ROCK1/ROCK2 siRNA
100 µm
20 µm 20 µm20 µm20 µm
100 µm100 µm100 µm
*
*
Y27632 Concentration (µM)
P
er
ce
nt
ag
e MLC Phosphorylation
Cloning Efficiency
* * *
*
ROCK1/ROCK2 siRNA ROCK1/ROCK2 siRNAControl
Figure 4. ROCKs Regulate Cell Survival through MLC Phosphorylation
(A–F) ROCKs regulate cell survival through MLC phosphorylation. Knockdown (by siRNA) of ROCK1 and ROCK2 (ROCK1/ROCK2) together (A) changed human
ESC morphology in colonies 96 hr after transfection, (B) decreased blebbing immediately after dissociation, (C) increased (*p < 0.05) cell survival 24 hr after
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reduced by the ROCK inhibitor Y27632 (10 mM) and was (F) reduced by siRNA knockdown ofROCK1/ROCK2. The results were confirmed by repeat experiments
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at increasing concentrations at time equal to zero. The treated cells were harvested 5 hr after plating and phosphorylation of MLC examined byWestern blotting.
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(H) A decrease in MLC phosphorylation levels correlated with improvements in cloning efficiency (*p < 0.05 compared to untreated control). Blue columns repre-
sent cloning efficiency, and red columns represent quantified MLC phosphorylation percentage from (G). The result was confirmed by repeat experiment (n = 2).
See also Figure S4 and Tables S2 and S3.
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Myosin-Dependent Cell Death in Human ESCsefficiency. We found that exposure to actin inhibitors, including
Cytochalasin D, Swinholide A, and Mycalolide B, improved initial
human ESC survival, and Swinholide A also improved ESC
cloning, but only with limited exposure time, and even then at
a lower efficiency than blebbistatin. Actin filaments are a major
cytoskeletal component that is involved not only in actin-myosin
contraction but also in other diverse functions, ranging fromRNA
transcription to chromatin remodeling (Zheng et al., 2009). Bleb-
bistatin should prevent myosin-actin contraction, but leave other
actin functions intact; however, the disruption of actin itself would
lead to the disruption of these other essential cellular functions.
It has been previously demonstrated that Rho-ROCK-Myosin
signaling axis regulates cell-cell integrity in human ESC colonies
(Harb et al., 2008). Our work shows the important role of this
pathway in response to cell dissociation. Our results suggest
that disruption of actin-myosin contraction is the mechanism
by which ROCK inhibitors increase the cloning efficiency of
human ESCs, given that ROCK inhibition reduces the phosphor-
ylation of MLC, an activator of actin-myosin contraction. Inter-
estingly, in contrast to actin andMYH inhibitors, long-term expo-
sure to ROCK inhibitors support both increased initial survival
and cloning efficiency of human ESCs. This suggests that
reduced MLC phosphorylation is sufficient to block initial cell
blebbing and death, but is not sufficient to block cleavage furrow
formation and cell division. It is consistent with our result that
ROCK inhibition by Y27362 and H1152 did not inhibit all detect-
able MLC phosphorylation (Figure 4G and Figure S4C), and the
residual MLC phosphorylation is presumably sufficient to
support cytokinesis. It is possible that ROCK is incompletely
inhibited, but it is also possible that other kinases are responsible
for the observed residual MLC phosphorylation, such as MLCK
(Kang et al., 2007; Krawetz et al., 2009). We found that MLCK
inhibitors failed to improve cell survival and cloning efficiency
of human ESCs (Figures S4F–S4I), and this failure correlated
with these inhibitors’ inability to suppress blebbing after dissoci-
ation (Figure S4E). One possible explanation for this difference in
response to ROCK and MLCK inhibitors is a spatial compart-
mentalization of the different phosphorylation events (Totsukawa
et al., 2004; Totsukawa et al., 2000).
Inhibition of actin-myosin contraction increased human ESC
survival even in suspension or when cultured on uncoated
plates. Unattached human ESCs initially survived well in the
presence of blebbistatin, but failed to proliferate, which was
not an unexpected result given the effects on cleavage furrow
formation and cell division. ROCK inhibition also improved cell
survival in suspension (Harb et al., 2008; Watanabe et al.,
2007); however, long-term growth was poor compared to cells
grown on matrigel-coated surfaces. This suggests that the
immediate cell death observed in cells deprived of surface
contact is probably related to actin-myosin contraction, but
that in nonattached conditions additional signals are still needed
to promote robust undifferentiated proliferation.
In summary, our results show that the death of individualized
human ESCs is executed by actin-myosin contraction, and that
inhibition of actin-myosin contraction by several approaches
leads to an increased cloning efficiency of both human ESCs
and iPSCs. These results provide a model for further studies on
the role of cytoskeleton organization in human pluripotent stem
cells.EXPERIMENTAL PROCEDURES
Human ESC Culture
Human ESCs were maintained in mTeSR medium on matrigel-coated tissue
culture plates (Ludwig et al., 2006). Cells were passaged and analyzed with
methods described in the Supplemental Experimental Procedures.
Cloning Assay
Unless specified, all the experiments were done on 12-well plates. Usually trip-
licates were prepared for each treatment. Prior to the addition of cells, 500 ml
media was loaded in each well. Cells were dissociated with TrypLE for 5 min or
until fully detached from the plate, neutralized with equal volumes of basic
media, counted, washed and diluted to 5000 cells/ml, and finally 100 ml
suspension was added into each well. Plates were then placed into 5% O2
and 10% CO2 37
C incubator. Small chemical compounds or proteins were
added or washed away according to the specified procedure. Media was
changed every 1–2 day(s) if not specified. After 5–6 days, colonies were
stained with an APS kit as standard procedure (Vector Lab), and counted.
siRNA Knockdown
Cells were passaged into mTeSR media one day before the transfection at
53105/well in six-well plates. Media was changed 2 hr before transfection.
Specific siRNA (200 pmol) was mixed with 4 ml Dharmacon siRNA Transfection
Reagent 1 as suggested in the standard protocol. For knockdown efficiency by
qRT-PCR, RNA was isolated 24 hr after transfection. For survival and cloning
experiment, cells were processed for survival and cloning analysis 72–96 hr
after transfection. If cell density was too high after transfection, cells were
passaged 24 hr after siRNA transfection.
Statistics
In cloning or survival assays, triplicate data were obtained for each condition.
A t test was performed so that p values for the difference between themeans of
the experimental conditions and control could be calculated. Each finding was
confirmed by three independent biological replicates, unless specified.
SUPPLEMENTAL INFORMATION
Supplemental Information include three tables, four figures, one movie, and
Supplemental Experimental Procedures and can be found with this article
online at doi:10.1016/j.stem.2010.06.017.
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